nuBioAge
DHH-B
DHH-B
Retail: $104.00
Regular price
Whsle: $89.00
Regular price
Sale price
Whsle: $89.00
Unit price
per
Couldn't load pickup availability
Order in quantities of 10 or more required.
Dihydrohonokiol (DHH-B) is a natural compound extracted from magnolia bark, known for its anxiolytic effects. It promotes a sense of calm without causing motor dysfunction, amnesia, or physical dependence. Unlike synthetic drugs, DHH-B doesn’t exacerbate side effects or lead to withdrawal symptoms.
As a potent form of honokiol, it offers a natural alternative for anxiety and stress management.
Cellular Pathways
Chronic administration of honokiol, a natural compound, results in the buildup of a metabolite called dihydrohonokiol-B (DHH-B), which is responsible for honokiol’s anxiolytic (anxiety-reducing) effects. DHH-B acts as a potent agent to reduce anxiety by targeting the GABA_A receptor-gated chloride channel complex in the brain, suggesting a specific mechanism through which DHH-B can alleviate anxiety
Why this matters:
Magnolia bark and its extracts need to be administered repeatedly to achieve their effects, whereas DHH-B (dihydrohonokiol-B) provides immediate anxiety-reducing benefits. Unlike benzodiazepines, a common class of anxiolytics, DHH-B does not lead to motor dysfunction or dependency. This underlines DHH-B’s promise as a therapeutic option for anxiety disorders, showcasing its capacity to alter neurotransmitter systems for effective anxiolytic outcomes without the significant side effects associated with many traditional medications.
